1. Bebenbaum, M. C.: Immunosuppression by platinum diammines. Brit. J. Cancer 25, 208–211 (1971).
2. Cleare, M. J., Hoeschele, J. D.: Anti-tumor platinum compounds: relationship between structure and activity. Platinum Metals Rev. 17, 2–13 (1973).
3. Coley, R. F., Frigerio, N. A.: Least squares adjustment of hydrolysis data for antitumor compounds of platinum(II). ANL-7635, U.S. A.E.C. Argonne Nat. Lab. 150–1, Dec. 1969.
4. Gale, G. R., Howle, J. A., Walker, E. M., Jr.: Antitumor and antimitogenic properties of cis-dichloro(dipyridine)platinum(II). Cancer Res. 31, 950–952 (1971).
5. Gale, G. R., Morris, C. R., Atkins, L. M., Smith, A. B.: Binding of an antitumor platinum compound to cells as influenced by physical factors and pharmacologically active agents. Cancer Res. 38, 813–818 (1973).